These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 18642670

  • 1. A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo.
    Adekar SP, Al-Saleem FH, Elias MD, Rybinski KA, Simpson LL, Dessain SK.
    Hybridoma (Larchmt); 2008 Apr; 27(2):65-9. PubMed ID: 18642670
    [Abstract] [Full Text] [Related]

  • 2. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T, Amatsu S, Misaki R, Yutani M, Du A, Kohda T, Fujiyama K, Ikuta K, Fujinaga Y.
    Toxins (Basel); 2020 May 07; 12(5):. PubMed ID: 32392791
    [Abstract] [Full Text] [Related]

  • 3. Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins.
    Adekar SP, Jones RM, Elias MD, Al-Saleem FH, Root MJ, Simpson LL, Dessain SK.
    J Immunol Methods; 2008 Apr 20; 333(1-2):156-66. PubMed ID: 18313069
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ.
    Immunobiology; 2012 Jan 20; 217(1):17-27. PubMed ID: 21962573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 13. A human monoclonal antibody that binds serotype A botulinum neurotoxin.
    Adekar SP, Jones RM, Elias MD, Al-Saleem FH, Root MJ, Simpson LL, Dessain SK.
    Hybridoma (Larchmt); 2008 Feb 01; 27(1):11-7. PubMed ID: 18294071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccines against botulism.
    Karalewitz AP, Barbieri JT.
    Curr Opin Microbiol; 2012 Jun 01; 15(3):317-24. PubMed ID: 22694934
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R, Zhao H, Al-Saleem FH, Ubaid AS, Puligedda RD, Segan AT, Lindorfer MA, Bermudez R, Elias M, Adekar SP, Simpson LL, Taylor RP, Dessain SK.
    Mol Immunol; 2014 Feb 01; 57(2):247-54. PubMed ID: 24184879
    [Abstract] [Full Text] [Related]

  • 20. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
    Tremblay JM, Vazquez-Cintron E, Lam KH, Mukherjee J, Bedenice D, Ondeck CA, Conroy MT, Bodt SML, Winner BM, Webb RP, Ichtchenko K, Jin R, McNutt PM, Shoemaker CB.
    Toxins (Basel); 2020 Sep 24; 12(10):. PubMed ID: 32987745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.